Medtronic announced that it received CE mark approval for its Percept RC neurostimulation device. The medtech giant labeled the deep brain stimulation (DBS) device as the smallest and thinnest device on the market. Also rechargeable, the system features BrainSense sensing technology. Medtronic says its launch marks the first release of a rechargeable DBS system with […]
Bioelectronic Medicine
5 more brain-computer interface companies you need to know
The brain-computer interface (BCI) space continues to rise in notoriety, and a number of players are throwing their hats in the ring. Such technologies could enable users to control a computer with their brain, or even go beyond that. Countless immobile people someday could control a mouse cursor, keyboard, mobile device/tablet, wheelchair or prosthetic device […]
Stimvia completes enrollment in study of neurostim for Parkinson’s
Stimvia announced today that it completed enrollment in a study of neuromodulation for treating Parkinson’s disease and essential tremor. The study evaluates the Czech Republic-based company’s Uris device, which uses peroneal neuromodulation (eTNM) for deep brain stimulation. The Uris system previously demonstrated high effectiveness in treating overactive bladder. Uris, a non-invasive system, utilizes active closed-loop […]
Onward spinal cord stimulation demonstrates improved mobility in study
Onward Medical announced a new publication demonstrating the impact of its ARC therapy to address gait challenges related to Parkinson’s disease. Eindhoven, the Netherlands-based Onward designed its ARC-IM stimulation system to deliver targeted, programmed therapy to the spinal cord. It aims to restore movement and other functions after spinal cord injury. The study, published in Nature […]
BrainsWay has positive data for its deep transcranial magnetic stimulation tech
BrainsWay (Nasdaq:BWAY) today announced new real-world, post-market data demonstrating the efficacy of its brain stimulation technology. The data supports the use of BrainsWay’s accelerated deep transcranial magnetic stimulation (Deep TMS) for treating major depressive disorder (MDD). Results were published in the peer-reviewed journal Psychiatry Research. Deep TMS uses specially designed H-coils to stimulate deep and broad cortical […]
Tivic Health regains Nasdaq compliance
Tivic Health (Nasdaq:TIVC) announced today that it regained compliance with the minimum bid price requirement on the Nasdaq market. Earlier this year, San Francisco-based Tivic filed an SEC Form 8-K pertaining to a notice of delisting from the Nasdaq market. The company received notice in January that its closing price fell below $1 for 30 […]
Boston Scientific targets M&A, AI to reach ‘next level’
Mike Mahoney uses fantasy football to describe Boston Scientific : He says that, if creating a medtech team, “it would be the draft you want.” Speaking at the company’s 2023 Investor Day event, the CEO set the theme as “next level.” He explained his aim to make Boston Scientific a “compelling” and “fantastic place to […]
InBrain Neuroelectronics wins FDA breakthrough nod for intelligent network modulation system
InBrain Neuroelectronics announced today that it received FDA breakthrough device designation for its intelligent network modulation system. The breakthrough nod covers the graphene-neural platform as an adjunctive therapy for treating Parkinson’s disease. InBrain’s system harnesses the power of graphene, a two-dimensional material made of a lattice of carbon atoms. The thin material — stronger than […]
Motif Neurotech completes first-in-human implant of miniature brain pacemaker
Motif Neurotech today announced new research highlighting the use of its millimeter-sized brain stimulator in a human subject. Houston-based Motif Neurotech develops a miniature brain pacemaker designed to precisely stimulate the brain. It restores healthy circuit activity to treat mental health disorders. The pea-sized implant, which goes in during a 20-minute outpatient procedure, has capabilities […]
Tivic Health begins non-invasive, bioelectronic vagus nerve stimulation trial
Tivic Health (Nasdaq:TIVC) announced today that its funded study for vagus nerve stimulation received Institutional Review Board (IRB) approval. San Francisco-based Tivic Health’s study takes place at the Feinstein Institutes for Medical Research. With IRB approval, the company can begin recruitment and enrollment for the study of its non-invasive bioelectronic nerve stimulation device. In collaboration with […]
Tivic Health prices $1.4M common stock offering ahead of special stockholder meeting
Tivic Health (Nasdaq:TIVC) announced that it priced a public offering of common stock at $1.4 million. San Francisco-based Tivic intends to offer 33.173 million shares of common stock at $0.041 per share. The company plans to use the net proceeds for working capital and general corporate purposes. Tivic expects the offering to close on or […]